Construction and verification of a prognostic model for cervical cancer based on genes associated with the p53 regulatory pathway
This study elucidates specific features associated with the p53 regulatory pathway, particularly <i>SMYD2</i>, and its relationship with the onset and progression of CESC. Furthermore, <i>SMYD2</i> may serve as a prognostic biomarker for individuals diagnosed with CESC, offering new insights for the development of clinical treatment strategies.
Authors
- Nan Wang (ORCID: https://orcid.org/0000-0003-2006-9999)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-4825-9674)
- Changqing Li (ORCID: https://orcid.org/0000-0003-4380-2284)
- Zhaoming Wu (ORCID: https://orcid.org/0000-0002-1429-6653)
- Bohao Sun (ORCID: https://orcid.org/0009-0000-8352-9839)
- Yichen Wu (ORCID: https://orcid.org/0009-0007-4810-174X)
Institutions
- Tongde Hospital of Zhejiang Province (CN)
- Zhejiang Provincial People's Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tcr-2025-687
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00